Articles

Podcasts

Videos

Rheumatology

Rheumatology condition center page is a comprehensive resource for clinical news and insights on rheumatologic disease. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for arthritis, gout, nr-AxSpA, and more.

Bimekizumab Offers Improvements Across Full Spectrum of Axial Spondyloarthritis in Phase 3 Trials

Pri-Med West presenter, Dr. Peng Thim Fan asks the questions that many rheumatologists have likely been contemplating now that disease treatment is so successful. 

Peng Thim Fan, MD: Can We Prevent Rheumatic Disease?

While some physicians might initially assume that oral medications like upadacitinib aren't as effective as an injection, but Dr. Fan explains that's not the case.

Peng Thim Fan, MD: The Advantages of Upadacitinib for Ankylosing Spondylitis

The newest indication for the AbbVie biologic marks the fifth for treating a chronic immune-mediated disease.

FDA Approves Upadacitinib for Adults with Ankylosing Spondylitis

Dr. Warrington discusses the details of glucocorticoids and how avacopan can help with the effective treatment of ANCA-associated vasculitis. 

Kenneth Warrington, MD: Reducing Glucocorticoids in ANCA-Associated Vasculitis

Patients with psoriatic arthritis and ankylosing spondylitis experienced rapid pain reduction with upadacitinib, regardless of treatment history.

Upadacitinib Improves Pain Associated with Ankylosing Spondylitis, PsA

The 2 studies focused on upadacitinib treatment for one group of patients with ankylosing spondylitis and another group of patients with non-radiographic axial spondyloarthritis.

Upadacitinib Phase 3 Clinical Trials Meet Primary and Most Ranked Secondary Endpoints

Investigators gathered data from vulnerable populations with rheumatic disease regarding their thoughts and opinions on the COVID-19 virus.

Investigation Confirms COVID-19 Concerns in People with Rheumatic Disease

A study finds low risk of malignancy from secukinumab treatment for psoriasis, psoriatic arthritis and ankylosing spondylitis patients, despite limited data.  

Malignancy Risk Low in Secukinumab Treatment 

A recent study finds increasing number of women with PsA, but an overall stable incidence of disease compared to previous studies in same population. 

Numbers of Incidence Stable in US Patients with Psoriatic Arthritis

On the HCPLive ankylosing spondylitis page, resources on the topics of medical news and expert insight into the inflammatory disease can be found. Content includes articles, interviews, videos, podcasts, and breaking news on ankylosing spondylitis, and more.

Ankylosing Spondylitis

Latest News